Terms: = Sarcomas AND NRG1, ENSG00000157168, 3084, SMDF, NDF, HRGA, HRG1, HGL, GGF2, GGF, ARIA AND Treatment
5 results:
1. Impact of tissue-agnostic approvals for patients with sarcoma.
Pestana RC; Beal JR; Parkes A; Hamerschlak N; Subbiah V
Trends Cancer; 2022 Feb; 8(2):135-144. PubMed ID: 34887213
[TBL] [Abstract] [Full Text] [Related]
2. The Unmet Needs of the Diagnosis, Staging, and treatment of Gastrointestinal Tumors.
Halama N; Haberkorn U
Semin Nucl Med; 2020 Sep; 50(5):389-398. PubMed ID: 32768003
[TBL] [Abstract] [Full Text] [Related]
3. Medical morbidities in endometrial cancer patients.
Tangjitgamol S; Khunnarong J; Srijaipracharoen S
Int J Gynecol Cancer; 2014 Nov; 24(9):1623-7. PubMed ID: 25275662
[TBL] [Abstract] [Full Text] [Related]
4. Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors.
Stonecypher MS; Byer SJ; Grizzle WE; Carroll SL
Oncogene; 2005 Aug; 24(36):5589-605. PubMed ID: 15897877
[TBL] [Abstract] [Full Text] [Related]
5. Expression of HER/erbB family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cells.
Ricci C; Landuzzi L; Rossi I; De Giovanni C; Nicoletti G; Astolfi A; Pupa S; Menard S; Scotlandi K; Nanni P; Lollini PL
Int J Cancer; 2000 Jul; 87(1):29-36. PubMed ID: 10861449
[TBL] [Abstract] [Full Text] [Related]